A recent study by Verma et al. [111] demonstrated that PD-1 blockade of sub-optimally primed CD8+ T cells in cancer-bearing hosts results in dysfunctional T cells that are unable to respond to subsequent antigen/vaccine stimulation. The gene discussed is PDCD1; the disease is cancer.